Coronavirus disease 2019 in patients with rheumatic immune-mediated diseases in a single University Hospital, matched case-control study and literature review.

David Martínez-López,Ivan Ferraz-Amaro,Diana Prieto-Peña,Lara Sánchez-Bilbao,Alba Herrero-Morant,Carmen Álvarez-Reguera,Fabricio Benavides-Villanueva,Cristina Corrales-Selaya,Martín Trigueros-Vázquez,Miguel Ángel González-Gay,Ricardo Blanco

Frontiers in medicine（2022）

引用 0|浏览5

暂无评分

摘要

R-IMID have a very similar clinical presentation when compared to the general population. There is a trend to an increased severity of the disease in patients with R-IMID.

查看译文

关键词

COVID-19,antirheumatic agents,autoimmune diseases,biologic agents,rituximab

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要